Non-Small-Cell Lung Carcinoma Clinical Trial
Official title:
Open-Label, Randomized Trial of Nivolumab (BMS-936558) Plus Pemetrexed/Platinum or Nivolumab Plus Ipilimumab (BMS-734016) vs Pemetrexed Plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor Therapy
The main purpose of this study is to determine whether nivolumab + chemotherapy is effective as compared to chemotherapy in the treatment of patients with EGFR mutation, NSCLC who failed first line (1L) or second-line (2L) EGFR TKI therapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00985855 -
Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT01048645 -
Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT00129844 -
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT00098085 -
Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04995523 -
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
|
Phase 1/Phase 2 | |
| Completed |
NCT00910676 -
Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
|
Phase 2 | |
| Withdrawn |
NCT00108186 -
Celecoxib Treatment for Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT05037825 -
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
|
||
| Recruiting |
NCT00379717 -
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
|
Phase 1/Phase 2 | |
| Completed |
NCT00404924 -
ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures
|
Phase 3 | |
| Completed |
NCT00102505 -
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
|
Phase 1 | |
| Recruiting |
NCT02905591 -
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
|
Phase 2 | |
| Active, not recruiting |
NCT03088540 -
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
|
Phase 3 | |
| Terminated |
NCT00271323 -
Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients
|
Phase 2 | |
| Terminated |
NCT00232206 -
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT00037817 -
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
|
Phase 1 | |
| Completed |
NCT03444766 -
Study of Nivolumab for Advanced Cancers in India
|
Phase 4 | |
| Completed |
NCT04351334 -
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
|
||
| Active, not recruiting |
NCT02416739 -
Anticancer Activity of Nicotinamide on Lung Cancer
|
Phase 2/Phase 3 | |
| Completed |
NCT00444015 -
Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)
|
Phase 1 |